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Having previously shown that CCL20/macrophage inflammatory protein 3␣ and tumor necrosis factor alpha
(TNF-␣) are released by polarized primary rat uterine epithelial cells (UEC) in response to Escherichia coli but
not to Lactobacillus rhamnosus, we sought to determine if epithelial cells are responsive to pathogen-associated
molecular patterns (PAMP), including lipopolysaccharide (LPS), lipoteichoic acid (LTA), and Pam3Cys, a
bacterial lipoprotein analog. Epithelial cells were grown to confluence on Nunc cell culture inserts prior to
apical treatment with PAMPs. In response to LPS, LTA, and Pam3Cys (EMC Microcollection GmbH, Tübingen, Germany), CCL20 levels increased (4- to 10-fold) while PAMPs caused increased TNF-␣ (1- to 4-fold)
in the medium collected after 24 h of incubation. Both apical and basolateral secretion of CCL20 and TNF-␣
increased in response to PAMPs, but treatments had no effect on cell viability and integrity, as measured by
transepithelial resistance. Time course studies of CCL20 and TNF-␣ release in response to Pam3Cys and LPS
indicated that CCL20 release peaked between 2 and 4 h after treatment, whereas TNF-␣ release was gradual
over the length of the incubation. Freeze-thaw and cell lysis experiments, along with actinomycin D studies,
suggested that CCL20 and TNF-␣ are synthesized in response to PAMP stimulation. Taken together, these
studies demonstrate that E. coli and selected PAMPs have direct effects on the production of CCL20 and TNF-␣
without affecting cell integrity. Since CCL20 is known to be both chemotactic and antimicrobial, the increase
in apical and basolateral release by UEC in response to PAMPs suggests a new mechanism of innate immune
protection in the female reproductive tract.
body, including the female reproductive tract (10, 28, 42).
CCL20, which is chemotactic for bone marrow-derived dendritic cell precursors, B cells, and memory T cells which express
the CCR6 receptor, is released by rat uterine epithelial cells
(UEC) and the human uterine epithelial cell line HHUA (8,
35, 52). CCL20 production has been studied in several other
tissues, including epithelial cells of the airways and the gastrointestinal tract (31, 34, 43). Beyond its role as a chemokine,
CCL20 is structurally and functionally similar to the family of
antimicrobial molecules known as ␤-defensins, which share an
affinity for the CCR6 receptor (23, 48). TGF-␤ is released by
polarized uterine epithelial cells in culture and can act as a
cytokine that can influence chemotaxis (8, 17, 18, 47, 58). This
molecule regulates uterine epithelial cell proliferation and apoptosis (46) and has recently been shown to influence antigen
presentation by uterine and vaginal cells (56, 58). TNF-␣ plays
a role in the acute response to infection and in apoptosis (26,
29). The fact that these cytokines are interconnected is exemplified by the ability of TNF-␣ to upregulate CCL20 transcription (51). In other studies, TGF-␤ downregulated the production of TNF-␣ (50). Both TGF-␤ and TNF-␣ have been shown
to play a role in regulating dendritic cell maturation and cell
trafficking (5, 17)
Previously, we and others have shown that uterine epithelial
cells are actively involved in immune protection through the
expression of polymeric immunoglobulin receptors that transport immunoglobulin A (IgA) from the uterine tissue to the
lumen (12, 45) as well as through the release into the lumen of
antimicrobial molecules, such as secretory leukocyte protease
inhibitor (SLPI), that are bactericidal to both gram-negative

Epithelial cells are the host’s first line of defense against
potential pathogenic microbes (6, 11). At mucosal surfaces,
including those of the female reproductive tract, epithelial cells
have evolved as part of the innate immune system, with antimicrobial functions as well as the ability to influence the presence and activity of immune cells. The innate immune system
differs from the adaptive immune system in the types and
specificities of receptors for antigens, the immediacy of the
response, and the cell types involved (24, 37). Innate immune
protection relies on conserved germ line-encoded receptors
and molecules that recognize conserved pathogen-associated
molecular patterns (PAMPs) found in groups of microorganisms. PAMPs are recognized by Toll-like receptors (TLRs)
that are expressed on many cell types, including macrophages
(22), dendritic cells (25), and epithelial cells (4). Lipoteichoic
acid (LTA), a bacterial cell wall component derived from
gram-positive bacteria, and Pam3Cys, a synthetic analog of
bacterial lipopeptides, bind TLR2/1 heterodimers. Lipopolysaccharide (LPS), from gram-negative bacteria, binds TLR4
homodimers (19–21).
Cells of the innate immune system regulate immune responses through the production of chemokines and cytokines,
including CCL20, transforming growth factor beta (TGF-␤),
and tumor necrosis factor alpha (TNF-␣), that recruit and
activate immune cells at mucosal surfaces throughout the
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and gram-positive bacteria (14, 54). In other studies, uterine
epithelial cells have been shown to present antigens through
class II molecules to T cells as part of the onset of adaptive
immunity (13, 57). More recently, we found that uterine epithelial cells in culture respond to the presence of live and
heat-killed Escherichia coli by releasing increased amounts of
CCL20 and TNF-␣ (8). In contrast, TGF-␤ release was inhibited by live E. coli. Unexpectedly, we found that live and
heat-killed Lactobacillus rhamnosus, a known commensal
found in the female reproductive tract (44), had no effect on
epithelial cell signaling.
The overall goal of the present study was to more fully define
the mechanism(s) through which uterine epithelial cells respond to a bacterial challenge. We tested the hypothesis that
primary rat uterine epithelial cells respond to bacterial cell wall
components, specifically LPS, LTA, and Pam3Cys, by releasing
CCL20, TNF-␣, and TGF-␤. Our objectives were to (i) establish whether selected PAMPs affect the release of CCL20,
TNF-␣, and TGF-␤ by rat epithelial cells, (ii) identify the
pattern of release of CCL20 and TNF-␣ in response to PAMP
exposure, and (iii) determine if CCL20 and TNF-␣ are produced de novo in response to PAMP stimulation.
MATERIALS AND METHODS
General procedures. Uterine epithelial cells were harvested from specificpathogen-free Lewis rats weighing from 125 to 175 g (Charles River Breeding
Laboratories, Kingston, N.Y.). The rats were maintained with alternating 12-h
dark-light cycles and were given free access to food and water. All procedures
involving animals were conducted according to protocols approved by the Dartmouth College Institutional Animal Care and Use Committee.
Preparation of epithelial cell cultures. All epithelial cell cultures described
here were primary cultures that were established by pooling the uteri of six or
more randomly selected animals at various stages of the estrous cycle. Rat uteri
were removed, rinsed in sterile ice-cold Hanks’ balanced salt solution (Gibco,
Grand Island, N.Y.), weighed, and then digested with pancreatin (Gibco), trypsin
(Sigma, St. Louis, Mo.), and DNase (Worthington, Lakewood, N.J.) (400 U of
DNase/ml of pancreatin, 46,500 U of trypsin/ml of pancreatin, 19.5 ml of pancreatin/g of uterine tissue) as previously described (8). The uteri were cut into
fine pieces and incubated for 1 h at 4°C, followed by an additional hour at room
temperature. The tissues were vortexed prior to passage through a sterile 250m-pore-size mesh screen. Epithelial cell sheets were recovered by pouring the
resulting suspension onto a 20-m-pore-size mesh capture screen. After being
rinsed to remove stromal contamination, UEC sheets were then collected, suspended in F12K medium (American Type Culture Collection, Rockville, Md.)
plus 10% fetal bovine serum supplemented with 100 g of streptomycin/ml and
100 U of penicillin/ml (complete F12K medium), and plated on growth factorreduced Matrigel-coated Nunc 10-mm by 0.4-m polycarbonate membrane inserts (Nalgene Nunc International) at a density of three to four cell culture insert
wells per rat uterus. Characterizations of epithelial cell cultures and preparation
were previously reported (45, 57).
Monitoring development of polarized epithelial cell cultures. Uterine epithelial cells were incubated in complete F12K medium at 37°C in 5% CO2 throughout the experimental period. Using established methods, we monitored the
development and polarization of viable UEC monolayer cultures by measuring
transepithelial resistance (TER) (16) on an EVOM voltohmmeter (World Precision Instruments). UEC were incubated with PAMPs only after a high TER
(1,000 to 3,500 ⍀/well), consistent with a confluent epithelial cell monolayer
devoid of stromal contamination, was established.
Heat-killed bacterial preparations. L. rhamnosus (ATCC 7469) and E. coli
(ATCC 29839) obtained from the American Type Culture Collection and grown
in sterile de Man, Rogosa, and Sharp broth and Trypticase soy broth, respectively, were maintained as previously described (8). Bacterial counts were determined by optical density analyses of bacterial saline suspensions, followed by
serial dilutions, plating on agar, and triplicate plate counting. For preparations of
heat-killed bacteria, L. rhamnosus and E. coli were grown to stationary phase,
suspended in sterile saline, and placed on ice for 2 h. The bacterial suspensions
were placed in sterile glass tubes and immersed in a 70°C water bath for 20 min.
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Heat-killed bacterial suspensions were cooled, vortexed, divided into aliquots,
and frozen at ⫺20°C.
Treatment of epithelial cells with heat-killed bacteria and PAMPs. LPS (from
E. coli) (L4391; Sigma), LTA (from Bacillus subtilis) (L3265; Sigma), Pam3Cys
(L2000; EMC Microcollections GmbH, Tübingen, Germany), and repurified
(ultrapure) LPS (from Salmonella minnesota) (R595; List Biological Laboratories, Campbell, Calif.) were reconstituted under sterile conditions. PAMPs were
tested by a Limulus assay (Limulus amebocyte lysate QCL-1000; Biowhittaker)
for the presence of endotoxin. Pam3Cys and LTA (1 g/ml) contained ⬍0.018
and 2.6 endotoxin units/ml, respectively. Ultrapure LPS (10 ng/ml) exceeded the
range of sensitivity of the assay. Cell cultures were treated with PAMPs in the
apical compartment. Fresh medium was placed in the apical and basolateral
compartments at the beginning of each treatment period. The basolateral medium was harvested at the end of the experimental period(s) for analysis.
Measurements of CCL20, TNF-␣, and TGF-␤. The amounts of CCL20 and
TNF-␣ were determined by use of an enzyme-linked immunosorbent assay
(ELISA) kit for rat macrophage inflammatory protein 3␣/CCL20 or rat TNF-␣
(DuoSet ELISA development system; R&D Systems, Minneapolis, Minn.). Biologically active TGF-␤ was measured by a bioassay using a mink lung epithelial
(MLE) cell line transfected with the plasminogen activator 1 promoter linked to
a luciferase reporter gene as previously described (8). This bioassay is based on
the MLE cell line’s specific sensitivity to picogram levels of biologically active
TGF-␤, which includes the expression of plasminogen activator 1 and results in
a consistent dose-dependent luciferase activity. Briefly, transfected MLE cells
were seeded into a 96-well plate at 105/100 l of medium/well and then were
spun in a Beckman centrifuge at 1,500 rpm for 15 s. After an initial 3-h incubation at 37°C, the medium was removed and replaced with 50 l of fresh medium
plus 50 l of serially diluted standard (recombinant human TGF-␤) or culture
medium. The cells were cultured for 17 h prior to lysing by the addition of 50 l
of cell culture lysis reagent (Promega)/well for 15 min. Luciferase activities were
determined by the responses of MLE cell lysates to 100 l of luciferase reagent
(Promega)/well for 10 s in a microplate luminometer (model LB96V; EG&G
Berthold, Gaithersburg, Md.).
Statistics. Data were compared by one-way analysis of variance followed by
Tukey’s multiple comparison posttest. Differences with P values of ⬍0.05 were
considered significant.

RESULTS
Influence of heat-killed E. coli and LPS on release of CCL20
and TNF-␣ by polarized uterine epithelial cells. We previously
showed that uterine epithelial cells, when grown to confluence
on cell culture inserts, respond to live and heat-killed E. coli
with increased CCL20 and TNF-␣ secretion into the basolateral chamber, while they show no change in cytokine release in
response to L. rhamnosus (8). To more fully understand the
nature of these bacterial interactions, we exposed epithelial
cell cultures to heat-killed bacteria and compared their levels
of responsiveness to LPS, an antigenic component of the gramnegative bacterial cell wall. Polarized rat uterine epithelial cells
grown on Nunc cell culture inserts in complete F12K medium
were treated apically with 106 CFU of heat-killed E. coli or L.
rhamnosus or 10 g of commercial-grade LPS/ml. After incubation for 24 h, the basolateral medium was harvested and
analyzed for CCL20 and TNF-␣ by ELISA. As shown in Fig. 1,
the presence of LPS at the apical surfaces of rat uterine epithelial cells increased the basolateral release of CCL20 and
TNF-␣, similar to what was seen for cultures treated with 106
CFU of heat-killed E. coli. As reported previously (8), apical
treatment of the UEC cultures with heat-killed L. rhamnosus
had no effect on the release of either CCL20 or TNF-␣. In all
cases, irrespective of the bacteria or PAMP used, the TER was
not significantly different from that of controls, consistent with
the presence of a viable polarized epithelial cell monolayer
(data not shown).
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FIG. 1. Effect of heat-killed bacteria and LPS on uterine epithelial
cell release of CCL20 (A) and TNF-␣ (B). Polarized rat uterine epithelial cells grown in F12K complete medium on Nunc cell culture
inserts were treated apically with heat-killed bacteria or LPS in complete medium. The basolateral medium was removed after a 24-h
incubation for analyses of CCL20/MIP-3␣ and TNF-␣ by ELISA. Values are means ⫾ standard errors (SE) for five wells per group. **,
significantly (P ⬍ 0.01) different from control. The data are representative of three separate experiments.

Response of uterine epithelial cells to apical treatment with
LPS, Pam3Cys, and LTA. To more fully characterize the interaction of PAMPs with polarized rat uterine epithelial cells,
we measured cytokine release and TER in response to treatment with increasing doses of LPS or LTA isolated from the
cell wall components of gram-negative (LPS) and gram-positive (LTA) bacteria. As shown in Fig. 2C, TERs of 1,000 to
1,500 ⍀/well were not affected when commercial-grade LPS or
LTA was added to the apical compartment for 24 h in doses
ranging from 0.1 to 1,000 ng/well. When the basolateral medium from cell cultures exposed to LPS was analyzed by
ELISA, CCL20 and TNF-␣ levels were shown to increase in a
dose-dependent manner (Fig. 2A and B). Moreover, we found
that LTA administered at 1,000 ng/ml, but not at lower doses,
also elicited an increase in CCL20 and TNF-␣.
Studies of cellular responses to LPS have shown that repurification of LPS by a phenol extraction of bacterial lipoproteins eliminates signaling through TLR2, suggesting that commercial-grade LPS is contaminated with fragments of other
bacterial cell wall components (21). To more fully define the
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FIG. 2. Dose response of rat uterine epithelial cells to LPS and
LTA. Rat uterine epithelial cells cultured on Nunc cell culture inserts
in F12K complete medium were treated apically with LPS or LTA in
complete medium. The basolateral medium was removed after a 24-h
incubation and analyzed by ELISA for CCL20 (A) and TNF-␣ (B).
(C) The TER was measured to determine the presence of a polarized
monolayer of UEC. Values are means ⫾ SE for five wells per group.
**, significantly (P ⬍ 0.01) different from control. Data are representative of three separate experiments.

response of UEC to bacterial antigens, we performed a doseresponse experiment in which epithelial cells were incubated
for 24 h with repurified ultrapure LPS, a pure agonist of TLR4.
Figure 3 indicates that ultrapure LPS increases the release of
CCL20 by polarized epithelial cells when it is added to the
apical compartment in doses ranging from 100 pg to 1 ng/ml. In
contrast, significantly more ultrapure LPS (10 to 100 ng/ml)
was needed to increase the basolateral release of TNF-␣ (not
shown). In other studies to determine if LPS affects the release
of biologically active TGF-␤ by UEC, we measured TGF-␤ in
the basolateral compartment. In contrast to the effect of live E.
coli, which decreases the release of TGF-␤ (8), we found that
neither commercial-grade LPS nor repurified LPS had any
effect on TGF-␤ release (data not shown).
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FIG. 3. Effect of repurified LPS on polarized uterine epithelial cell
production of CCL20 and TNF-␣. Uterine epithelial cells cultured in
F12K complete medium on Nunc cell culture inserts were treated
apically with ultrapure LPS in complete medium and then incubated
for 24 h. After collection of the basolateral medium, cytokine levels
were determined by ELISA. The values shown are means ⫾ SE for
groups of four to five wells. *, significantly different from control (P ⬍
0.05); **, significantly different from control (P ⬍ 0.01). The data are
representative of three separate experiments.

To analyze the effects of a TLR2/1 agonist, we added
Pam3Cys, a known bacterial lipoprotein analog, to the apical
surfaces of UEC prior to incubation for 24 h. As shown in Fig.
4, in the presence of increasing doses of Pam3Cys, CCL20
release increased relative to that in control cells (Fig. 4A)
without affecting the TER (data not shown). Interestingly, only
the highest dose of Pam3Cys used increased the amount of
basolateral TNF-␣ (Fig. 4B).
Apical versus basolateral release of CCL20 and TNF-␣ by
apically treated uterine epithelial cells. Previously, we showed
that in unstimulated uterine epithelial cell cultures, CCL20 is
preferentially released into the basolateral compartment while
preferential TNF-␣ release is apical (8). To determine if directional release is altered in cell cultures treated with PAMP,
we treated UEC apically with 1 g of ultrapure LPS or
Pam3Cys/ml. As shown in Fig. 5A, both apical and basolateral
CCL20 levels increased in response to PAMP treatment without altering the directional release seen with untreated UEC
cultures.
Time course of CCL20 and TNF-␣ release by uterine epithelial cells stimulated with repurified LPS and Pam3Cys. To
determine the patterns of CCL20 and TNF-␣ release in response to repurified LPS and Pam3Cys, we allowed rat uterine
epithelial cells to grow to confluence on Nunc cell culture
inserts for various times in the presence or absence of a PAMP.
The cultures were treated apically with 1 g of LPS or
Pam3Cys/ml. For this study, inserts containing epithelial cells
were transferred to new wells containing fresh medium at 2-h
intervals. As shown in Fig. 6A, LPS and Pam3Cys had minimal
effects on CCL20 during the first 2-h interval, after which the
levels peaked between 2 and 4 h. While its level was partially
elevated between 4 and 6 h, CCL20 then declined to baseline
levels by 12 h. Figure 6B shows the cumulative pattern of
release of CCL20, which indicates that cultures stimulated with
Pam3Cys release less CCL20 than cells stimulated with the

FIG. 4. Basolateral release of CCL20 (A) and TNF-␣ (B) by epithelial cells in response to increasing doses of Pam3Cys. Primary rat
uterine epithelial cells were grown to polarized monolayers on Nunc
cell culture inserts and then treated apically with Pam3Cys in complete
F12K medium. The basolateral compartments received fresh complete
F12K medium at the time of treatment. The basolateral medium was
collected after a 24-h incubation. The values shown are means ⫾ SE
for four wells per group. **, significantly (P ⬍ 0.01) different from
control cultures that were treated with medium without Pam3Cys. The
data are representative of three separate experiments.

same amount of LPS. In contrast, the release of TNF-␣ over
time was gradual and was not significantly different from that
seen in control wells, in part due to the limits of detection of
our assay (data not shown).
CCL20 and TNF-␣ synthesis in response to treatment with
actinomycin D and cell lysis studies. A study was undertaken
to determine if CCL20 and TNF-␣ are synthesized by uterine
epithelial cells in response to LPS. Primary cultures that had
grown to confluence in Nunc cell culture inserts were treated in
the apical compartment with 100 ng of ultrapure LPS/ml. Actinomycin D was added to the medium in both the apical and
basolateral chambers at the time of addition of LPS. After 8 h
of exposure, the basolateral medium was collected and analyzed for the presence of CCL20 and TNF-␣. As shown in Fig.
7A, the release of CCL20 in response to LPS was completely
inhibited at all doses of actinomycin D (1 to 100 g/ml). In
contrast, as indicated in Fig. 7B, TNF-␣ release in response to
LPS was not affected by actinomycin D at 1 g/ml but was
gradually inhibited with increasing doses of actinomycin D (5
to 100 g/ml).
To more fully define whether CCL20 and TNF-␣ were syn-
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FIG. 5. Increased apical and basolateral release of CCL20 and
TNF-␣ by uterine epithelial cells when stimulated apically with
PAMPs. Uterine epithelial cells cultured in complete F12K medium on
Nunc cell culture inserts were treated apically with 1 g of ultrapure
LPS or Pam3Cys/ml and then incubated for 24 h. After collection of the
apical and basolateral media, the cytokine levels were determined by
ELISA. The values shown are means ⫾ SE for groups of five wells. *,
significantly different from the control for the same compartment (P ⬍
0.05); **, P ⬍ 0.001. The data are representative of two separate
experiments.

thesized by epithelial cells in response to LPS, we conducted
cell lysis studies to evaluate directly whether epithelial cells
contained sufficient intracellular CCL20 and TNF-␣ levels to
account for their release into the culture medium. Polarized
cell cultures were treated with fresh medium, with or without
LPS. At time zero, some cultures were treated with fresh medium and removed for subsequent lysis by freezing or homogenization (PowerGen Tissue Homogenizer; Fisher Scientific).
Other cultures were incubated for 8 h in the presence or
absence of LPS, after which cells as well as the culture medium
from apical and basolateral compartments were collected. The
cells were then lysed by freezing or by homogenization as
previously described (59). As shown in Fig. 8A and B, the
epithelial cell contents of CCL20 and TNF-␣ at time zero were
either close to or below the level of detection of our assay.
When cells were incubated for 8 h, the amounts of CCL20 and
TNF-␣ released into the medium were low but measurable. In
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FIG. 6. (A) Time course of CCL20 release in response to ultrapure
LPS and Pam3Cys. (B) Cumulative pattern of CCL20 release over
time. Polarized uterine epithelial cells grown on Nunc cell culture
inserts in complete F12K medium were treated apically with 1 g of
ultrapure LPS or Pam3Cys/ml. At the start of the experiment and at
2-h intervals thereafter, the culture inserts were moved to new wells
containing fresh medium. The results, as determined by ELISA analysis of the basolateral medium, are representative of five wells per
group in two separate experiments.

contrast, when cells were incubated for 8 h with LPS prior to
measuring the apical and basolateral media, significantly
higher levels of CCL20 and TNF-␣ were found in the medium.
Overall, these studies demonstrate that the amounts of CCL20
and TNF-␣ measured in cells prior to LPS treatment are insufficient to account for those released into the culture medium. These results, when considered along with our findings
using actinomycin D, indicate that CCL20, and possibly
TNF-␣, is produced by UEC in response to LPS treatment.
DISCUSSION
The studies presented here demonstrate that polarized rat
uterine epithelial cells are responsive to PAMPs. We showed
that Pam3Cys and LTA, which are specific ligands of TLR2,
and LPS, which binds TLR4, stimulate the basolateral release
of CCL20 and TNF-␣ by epithelial cells. Moreover, we showed
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FIG. 7. Effect of actinomycin D on CCL20 (A) and TNF-␣ (B) synthesis. Rat uterine epithelial cells were grown on Nunc cell culture
inserts in complete F12K medium prior to incubation in medium
containing actinomycin D (apical and basolateral) and/or ultrapure
LPS (apical). After an 8-h incubation, the basolateral medium was
collected and analyzed by ELISA for CCL20 and TNF-␣. The data are
representative of four to five wells per group in two separate experiments.

that the preferential release of TNF-␣ from the apical, or
luminal, surfaces of UEC is maintained in response to PAMP
stimulation, while CCL20 release, similar to a constitutive release pattern, is preferentially released to the basolateral, or
stromal, surfaces of these cells. These studies demonstrate a
rapid induction and basolateral release of CCL20 by primary
polarized uterine epithelial cells between 2 and 4 h after apical
treatment with LPS or Pam3Cys. An actinomycin D treatment
of cell cultures inhibited the release of CCL20 and TNF-␣.
When considered in conjunction with cell lysis studies showing
the presence of only small amounts of intracellular CCL20 and
TNF-␣ in the absence of LPS treatment, these studies suggest
that CCL20 and TNF-␣ are synthesized by UEC in response to
bacterial stimulation.
The basolateral cytokine release by uterine epithelial cells in
response to LPS parallels the effects of treatment with E. coli.
Previously, we demonstrated that both live and heat-killed E.
coli placed at the apical or luminal surfaces of polarized primary rat uterine epithelial cells resulted in an increase in
basolateral CCL20 and TNF-␣ release (8). The present study
extends these findings by showing that treatment with LPS, a
cell wall component of gram-negative bacteria, elicits a pattern

481

FIG. 8. Cell lysis studies of total CCL20 and TNF-␣ produced by
LPS- or medium-treated cells. Polarized uterine epithelial cells were
grown on cell culture inserts as previously described. At time zero,
fresh medium was placed into the apical and basolateral compartments, and the cells were treated with LPS or medium alone. After an
8-h incubation, the apical and basolateral media were collected. Cell
lysis at time zero and after 8 h was performed with fresh medium by a
freeze-thaw method or by mechanical homogenization. The bars for
the 8-h data show the total amounts of cytokine produced by each
group, including apical and basolateral release. The zero time point
analysis shows cell-associated CCL20 and TNF-␣. The results are
means ⫾ SE for three to four wells per group and are representative
of two separate experiments.

of cytokine release similar to that seen when the cell cultures
were stimulated with E. coli, a gram-negative species. In contrast to the case for E. coli, our previous studies showed that
UEC exposure to L. rhamnosus, which is gram positive, has no
effect on the release of either CCL20 or TNF-␣. Unexpectedly,
in the present study we found that LTA, a component of
gram-positive bacterial cell walls, increased the levels of
CCL20 and TNF-␣. Moreover, Pam3Cys, which like LTA is a
ligand of TLR2, also increased CCL20 and TNF-␣ release.
One explanation for the differences seen between L. rhamnosus, LTA, and Pam3Cys may be that cell wall components of
the live and heat-killed gram-positive bacteria used in previous
experiments did not reach the surfaces of epithelial cells. This
may be attributed to the strong cell wall of gram-positive bacteria such as lactobacilli, which are less prone to fragmentation
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than cell walls from gram-negative bacteria such as E. coli (53).
Alternatively, uterine epithelial cells are known to produce
mucin and surfactants that act as physical or chemical barriers
to prevent bacteria from interacting with epithelial cell receptors (2, 9, 36, 39). Purified antigens (PAMPs) such as LPS,
LTA, and Pam3Cys may pass through this barrier to interact
with the cell surface receptors. Our studies suggest that once
this barrier is breached, epithelial cells are able to recognize
PAMPs of gram-negative as well as gram-positive bacteria to
elicit an immune response. Studies are under way to determine
whether differences seen with whole bacteria and PAMPs are
due to bacterial exclusion.
Previous studies in our laboratory and by others have shown
that the epithelium of the uterus, similar to epithelia at other
mucosal sites, is supported by an underlying population of
immune cells that are dispersed as well as present as lymphoid
aggregates made up of a B-cell core surrounded by T cells with
an outer halo of macrophages (27, 38, 60). The hypothesis that
CCL20 production by epithelial cells plays a role in the recruitment of immune cells to the female reproductive tract was
suggested by knockout studies of CCR6, the unique receptor
for CCL20 (7, 55). In the absence of CCR6, Peyer’s patches in
the gut are underdeveloped, with dendritic cells being absent
from the subepithelial dome. Our previous studies suggested
that immune cell recruitment to the female reproductive tract
may be due in part to the constitutive release of CCL20 (8).
The present study further indicates that epithelial cells respond
to PAMPs with a rapid release of CCL20, possibly to enhance
further immune cell traffic to those sites in the uterus that are
exposed to potential pathogens. Our findings of only small
amounts of CCL20 and TNF-␣ in epithelial cells in the absence
of stimulation (lysis and actinomycin D studies) suggest that in
response to PAMPs, CCL20 and TNF-␣ are rapidly synthesized and released by UEC to mount a robust response under
conditions that simulate infection. These findings, however, do
not exclude the possibility that CCL20 and TNF-␣ exist as
preformed cytokines whose processing under transcriptional
control, since measurable TNF-␣ requires that membrane-anchored TNF-␣ precursors be released by proteolytic cleavage
(15).
Others have demonstrated that commercial-grade LPS contains both LPS and lipoproteins (21). To more fully define the
specificity of TLR signaling, Hirschfeld and colleagues developed a phenol extraction process to eliminate bacterial lipoproteins from LPS (21). The use of refined ultrapure LPS
led to the conclusion that LPS binding signals through TLR4
and not through TLR2, which binds to bacterial lipoproteins
and other ligands (3, 49). Our finding that repurified LPS
stimulates the release of CCL20 supports our hypothesis that
TLR4 is present and functional on uterine epithelial cells.
Since epithelial cells respond to ultrapure LPS added to the
apical surface, TLR4 may be present on the apical surfaces of
rat uterine epithelial cells. An alternative interpretation of
these findings is that PAMPs may move through epithelial cells
to interact with TLRs at the basolateral surface. For example,
in experiments with epithelial cell lines derived from gastrointestinal enterocytes, TLR4 was shown to be present only on the
basolateral surface (1). Studies are under way to identify the
sites on epithelial cells at which TLR2 and TLR4 are expressed.
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We previously showed that polarized uterine epithelial cells
in culture preferentially release TNF-␣ into the apical compartment and CCL20 into the basolateral compartment (8).
Our findings in the present study extend these observations by
showing that preferential release is not altered but rather is
enhanced upon PAMP treatment. Also, irrespective of the
PAMP tested, the TER, which is a measure of the UEC monolayer integrity (16), was not affected. The continuity of the
TER, when coupled with the patterns of cytokine release in
response to PAMPs as well as to live and heat-killed bacteria
(8), suggests that in response to bacterial antigens, UEC are
able to maintain an epithelial barrier and to signal to immune
cells.
The movement of vaginal contents, including microbes and
microbial debris, into the upper reproductive tract (32, 33)
represents an ongoing challenge for the immune system in the
reproductive tracts of mammals. Uterine innate and adaptive
immune responses must balance the dual requirements of neutrality toward sperm and fetal or placental antigens and the
need to recognize and respond to potentially pathogenic bacteria. Recent studies of the innate immune system indicate that
beyond their barrier function, uterine epithelial cells release
antimicrobial molecules, including ␤-defensins and SLPI (14,
30, 54). These molecules, along with the transport of IgA and
the synthesis of complement (40, 41), provide a level of protection against bacteria that periodically enter the cervix,
uterus, and fallopian tubes. CCL20 shares structural and functional characteristics with ␤-defensins (23, 48). CCL20 and
␤-defensins are antimicrobial, and both bind the CCR6 receptor. The recognition that UEC produce CCL20 demonstrates
that the innate immune system in the uterus contains previously undefined antimicrobial agents that are potentially protective against gram-negative and gram-positive bacteria. Our
findings of a dose-dependent release of CCL20 in response to
Pam3Cys and to ultrapure LPS suggest that the uterine epithelium has evolved to be responsive to pathogens at mucosal
surfaces as well as to those that penetrate the epithelial lining.
Our finding that CCL20 is produced (8) and stimulated in
response to PAMPs suggests an important new arm of innate
immune protection in the uterus. Whether PAMP-induced
signaling stimulates ␤-defensin and SLPI production in addition to cell recruitment remains to be determined. What is
clear is that the uterine epithelial cell response to PAMP is
rapid, as determined by the pattern of CCL20 release. These
findings suggest that in response to bacterial antigens, epithelial cells are able to mobilize immune protection (innate and
adaptive) within hours of an antigenic challenge.
In conclusion, CCL20 and TNF-␣ are synthesized and secreted by uterine epithelial cells in response to stimulation by
known agonists of TLRs. The responsiveness to these antigens
suggests that the uterine epithelium plays a crucial role in
alerting supportive mucosal immune cells to the presence of
both commensal and pathogenic bacteria in the reproductive
tract to fine tune the immune state in order to optimize conditions for successful mammalian reproduction.
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